₹ 2.6 Cr
Volume transacted
24.7 K
stocks traded
Last Updated time: 20 Sep 15:30 PM
Zydus Lifesciences Ltd
BSE
20 Sep, 2024
1055.41.0 (0.1%)
Prev Close
1054.35
Open Price
1056
Bid Price (QTY)
0.0 (0)
Offer Price (QTY)
0.0 (0)
Volume
24700
Today's High / Low
1067.8 / 1047.3
52 WK High / Low
1323.9 / 567.8
NSE
20 Sep, 2024
1054.60.2 (0.0%)
Prev Close
1054.45
Open Price
1054.1
Bid Price (QTY)
0.0 (0)
Offer Price (QTY)
1054.6 (146)
Volume
2737320
Today's High / Low
1067.8 / 1046.8
52 WK High / Low
1324.3 / 567.8
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
19 Sep 2024 | 1054.35 | 1099.6 | 1099.6 | 1042.65 |
18 Sep 2024 | 1079.35 | 1110.55 | 1111 | 1066.7 |
17 Sep 2024 | 1110.35 | 1117.1 | 1122 | 1107.4 |
16 Sep 2024 | 1115.65 | 1135.95 | 1135.95 | 1114.25 |
13 Sep 2024 | 1118.5 | 1129.5 | 1129.5 | 1111.15 |
12 Sep 2024 | 1120.15 | 1125.7 | 1134.9 | 1116.55 |
11 Sep 2024 | 1112.2 | 1124.9 | 1128 | 1109.65 |
10 Sep 2024 | 1112.5 | 1114.45 | 1121.15 | 1107.6 |
09 Sep 2024 | 1104.55 | 1094.05 | 1109.35 | 1088.25 |
06 Sep 2024 | 1100.5 | 1116.05 | 1119.85 | 1097.7 |
Date | Price |
---|---|
19 Sep 2024 | 1054.35 |
18 Sep 2024 | 1079.35 |
17 Sep 2024 | 1110.35 |
16 Sep 2024 | 1115.65 |
13 Sep 2024 | 1118.5 |
12 Sep 2024 | 1120.15 |
11 Sep 2024 | 1112.2 |
10 Sep 2024 | 1112.5 |
09 Sep 2024 | 1104.55 |
06 Sep 2024 | 1100.5 |
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Entity | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
---|
Cipla Ltd | -1.1 | 4.0 | 5.1 | 14.1 | 32.3 | 74.5 | 263.0 | 161.0 |
Dr Reddys Laboratories Ltd | -2.6 | -5.8 | 9.3 | 6.0 | 16.0 | 36.2 | 138.3 | 102.2 |
Torrent Pharmaceuticals Ltd | -3.2 | 0.1 | 16.2 | 34.1 | 77.9 | 119.8 | 293.9 | 691.3 |
Sun Pharmaceuticals Industries Ltd | -1.0 | 5.7 | 22.8 | 19.0 | 60.2 | 144.1 | 349.4 | 128.8 |
Zydus Lifesciences Ltd | -5.9 | -11.0 | -1.8 | 8.7 | 68.8 | 93.0 | 343.5 | 310.6 |
Divis Laboratories Ltd | -0.8 | 16.4 | 21.4 | 57.8 | 43.8 | 6.4 | 243.7 | 534.4 |
Entity | 1W |
---|---|
Cipla Ltd | -1.1 |
Dr Reddys Laboratories Ltd | -2.6 |
Torrent Pharmaceuticals Ltd | -3.2 |
Sun Pharmaceuticals Industries Ltd | -1.0 |
Zydus Lifesciences Ltd | -5.9 |
Divis Laboratories Ltd | -0.8 |
Last updated time: 20 Sep 15:30 PM
Parameter | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|
Sales | 9572 | 11954 | 13166 | 14253 | 14404 | 15110 | 17237 | 19547 |
Sales YoY Gr. | - | 24.9% | 10.1% | 8.3% | 1.1% | 4.9% | 14.1% | 13.4% |
Adj EPS | 14.48 | 17.07 | 18.08 | 11.48 | 20.87 | 44.65 | 19.74 | 38.31 |
YoY Gr. | - | 17.9% | 5.9% | -36.5% | 81.8% | 113.9% | -55.8% | 94.1% |
Adj Net Profit | 1483 | 1748 | 1852 | 1176 | 2138 | 4572 | 1997 | 3854 |
BVPS | 67.97 | 85.4 | 101.43 | 101.33 | 126.88 | 166.01 | 173.08 | 197.11 |
Parameter | 2017 |
---|---|
Sales | 9572 |
Sales YoY Gr. | - |
Adj EPS | 14.48 |
YoY Gr. | - |
Adj Net Profit | 1483 |
BVPS | 67.97 |
Parameter | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|
Return on Capital Emp. % | 22.75 | 28.06 | 16.02 | 17.97 | 15.65 | 11.91 | 15.12 | 14.43 | 16.25 | 23.94 |
Op. Profit Mgn % | 20.43 | 25.41 | 21.2 | 24.61 | 24.11 | 20.43 | 23.86 | 23.61 | 23.35 | 29.04 |
Net Profit Mgn % | 13.46 | 19.98 | 15.49 | 14.62 | 14.07 | 10.33 | 16.48 | 29.6 | 14.07 | 19.72 |
Debt to Equity % | 0.7 | 0.51 | 0.6 | 0.68 | 0.7 | 0.77 | 0.54 | 0.29 | 0.16 | 0.05 |
Parameter | 2015 |
---|---|
Return on Capital Emp. % | 22.75 |
Op. Profit Mgn % | 20.43 |
Net Profit Mgn % | 13.46 |
Debt to Equity % | 0.7 |
No data available
No data available
Sun Pharmaceuticals Industries Ltd
Sun Pharmaceutical Industries Limited including its subsidiaries and associates ...
Divis Laboratories Ltd
Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the w...
Cipla Ltd
The Company is in the business of manufacturing, developing, and marketing wide ...
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is o...
Dr Reddys Laboratories Ltd
Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company...
FAQs for of Zydus Lifesciences Ltd
What factors influence the share price of Zydus Lifesciences Ltd over time?
What are the key events that typically impact Zydus Lifesciences Ltd's share price history?
How do stock splits affect Zydus Lifesciences Ltd's share price history?
How do dividends impact the share price history of Zydus Lifesciences Ltd?
How do corporate announcements affect Zydus Lifesciences Ltd’s share price history?
How can I use technical analysis to understand Zydus Lifesciences Ltd’s share price history?
Unlimited trading at just
Rs. 199*